Trial intelligence / Profile preview

HISTAP: High vs Standard BP Target in Hypertensive Surgical Patients

NCT05637606Completed

Sponsor
Humanitas Research Hospital
Start
Mar 2023
Primary completion
May 2025
Countries
1
01

Overview

Randomised, single-blind trial (2 arms), sponsored by Humanitas Research Hospital. Primary endpoint: Composite of 30-day mortality and major organ dysfunction. Started Mar 2023; status: completed.

Beyond the preview

Go deeper on NCT05637606.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05637606.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call